MKI67 and melanoma: Although greater frequencies of CD8 Ki-67+ cells have been associated with superior outcomes in the context of checkpoint blockade in melanoma (20), emerging data suggest that early dysfunctional cells are the major intratumorally proliferating (and Ki-67 expressing) compartment (21) suggesting that high frequency of CD8 Ki-67+ may be indicative of T cell dysfunction.